Induction of cell retraction by the combined actions of Abl - CrkII and Rho - ROCK1 signaling

Journal of Cell Biology

Volumn 183, Issue 4, 2008, Pages 711-723

  Huang, Xiao Dong ^a,b   Wu, Diana ^b   Jin, Hua ^a,b   Stupack, Dwayne ^b   Wang, Jean Y J ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; C3G PROTEIN; CRKII PROTEIN; EPHRIN A1; GUANINE NUCLEOTIDE EXCHANGE FACTOR; LYSOPHOSPHATIDIC ACID; PROTEIN DERIVATIVE; RAP1 PROTEIN; RHO FACTOR; ROCK1 PROTEIN; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG; LYSOPHOSPHOLIPID; ONCOPROTEIN; RHO KINASE; ROCK1 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CELL ACTIVITY; CELL RETRACTION; DOWN REGULATION; EMBRYO; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; EPHRIN-A1; GUANINE NUCLEOTIDE-RELEASING FACTOR 2; HUMANS; LYSOPHOSPHOLIPIDS; MALE; PROTO-ONCOGENE PROTEINS C-ABL; PROTO-ONCOGENE PROTEINS C-CRK; RAP1 GTP-BINDING PROTEINS; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION;

EID: 58149177451     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200801192     Document Type: Article

References (84)

1. Anafi , M., M.K. Rosen, G.D. Gish, L.E. Kay , and T. Pawson. 1996. A potential SH3 domain-binding site in the Crk SH2 domain. J. Biol. Chem. 271:21365-21374.
2. Barilá , D. , and G. Superti-Furga . 1998 . An intramolecular SH3-domain interaction regulates c-Abl activity. Nat. Genet. 18:280-282.
3. Bertoni, A., S. Tadokoro, K. Eto, N. Pampori, L.V. Parise, G.C. White, and S.J. Shattil. 2002. Relationships between Rap1b, aff nity modulation of integrin alpha IIbbeta 3, and the actin cytoskeleton. J. Biol. Chem. 277:25715-25721.
4. Bos, J.L.,B.Franke,L.M'Rabet, K.Reedquist, and F. Zwartkruis. 1997.Insearch of a function for the Ras-like GTPase Rap1. FEBS Lett. 410:59-62.
5. Bos, J.L., J. de Rooij, and K.A. Reedquist. 2001. Rap1 signalling: adhering to new models. Nat. Rev. Mol. Cell Biol. 2:369-377.
6. Brantley-Sieders, D.M., J. Caughron, D. Hicks, A. Pozzi, J.C. Ruiz, and J. Chen. 2004 . EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation. J. Cell Sci. 117:2037-2049.
7. Burton, E.A., R. Plattner, and A.M. Pendergast. 2003. Abl tyrosine kinases are required for infection by Shigella f exneri. EMBOJ. 22:5471-5479.
8. Burton , E.A. , T.N. Oliver , and A.M. Pendergast . 2005 . Abl kinases regulate actin comet tail elongation via an N-WASP-dependent pathway. Mol. Cell. Biol. 25:8834-8843.
9. Caron, E., A.J. Self, and A. Hall. 2000. The GTPase Rap1 controls functional activation of macrophage integrin alphaMbeta2 by LPS and other inf ammatory mediators. Curr. Biol. 10:974-978.
10. Chambers, A.F., G.N. Naumov , S.A. Vantyghem, and A.B. Tuck. 2000. Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic ineffciency. Breast Cancer Res. 2:400-407.
11. Donaldson, L.W., G. Gish, T. Pawson, L.E. Kay, and J.D. Forman-Kay. 2002. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide. Proc. Natl. Acad. Sci. USA. 99:14053-14058.
12. Eden, S., R. Rohatgi, A.V. Podtelejnikov, M. Mann, and M.W. Kirschner. 2002. Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. Nature. 418:790-793.
13. Fang, W.B., R.C. Ireton, G. Zhuang, T. Takahashi, A. Reynolds, and J. Chen. 2008 . Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism. J. Cell Sci. 121:358-368.
14. Feller, S.M. 2001 . Crk family adaptors - signalling complex formation and biological roles. Oncogene. 20:6348-6371.
15. Feller, S.M., B. Knudsen, and H. Hanafusa. 1994. c-Abl kinase regulates the protein binding activity of c-Crk. EMBOJ. 13:2341-2351.
16. Franke, B., J.W. Akkerman, and J.L. Bos. 1997. Rapid Ca2+-mediated activation of Rap1 in human platelets. EMBO J. 16:252-259.
17. Frasca, F., P. Vigneri, V. Vella, R. Vigneri, and J.Y. Wang . 2001. Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor. Oncogene. 20:3845-3856.
18. Fujisawa, K.,A. Fujita, T. Ishizaki,Y. Saito, and S. Narumiya. 1996. Identif cation of the Rho-binding domain of p160ROCK, a Rho-associated coiled-coil containing protein kinase. J. Biol. Chem. 271:23022-23028.
19. Ginsberg, M.H., A. Partridge, and S.J. Shattil. 2005. Integrin regulation. Curr. Opin. Cell Biol. 17:509-516.
20. Gong, J.G., A. Costanzo, H.Q. Yang, G. Melino, W.G. Kaelin Jr., M. Levrero, and J.Y. Wang . 1999 . The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature. 399:806-809.
21. Gotoh, T., S. Hattori, S. Nakamura, H. Kitayama, M.Noda,Y.Takai, K. Kaibuchi, H. Matsui, O. Hatase, H. Takahashi, et al. 1995. Identif cation of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol. Cell. Biol. 15:6746-6753.
22. Gotoh, T., D. Cai, X. Tian, L.A. Feig, and A. Lerner . 2000. p130Cas regulates the activity of AND-34, a novel Ral, Rap1, and R-Ras guanine nucleotide exchange factor. J. Biol. Chem. 275:30118-30123.
23. Hall, A., and C.D. Nobes. 2000. Rho GTPases: molecular switches that control the organization and dynamics of the actin cytoskeleton. Philos. Trans. R. Soc. Lond. B Biol. Sci. 355:965-970.
24. Hantschel, O., and G. Superti-Furga . 2004 . Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nat. Rev. Mol. Cell Biol. 5:33-44.
25. Hantschel, O., S. Wiesner, T. Guttler , C.D. Mackereth, L.L. Rix, Z. Mikes, J. Dehne, D. Gorlich, M. Sattler, and G. Superti-Furga . 2005 . Structural basis for the cytoskeletal association of Bcr-Abl/c-Abl. Mol. Cell. 19:461-473.
26. Harbott, L.K., and C.D. Nobes . 2005 . A key role for Abl family kinases in EphA receptor-mediated growth cone collapse. Mol. Cell. Neurosci. 30:1-11.
27. Hart, M.J., X. Jiang, T. Kozasa, W. Roscoe, W.D. Singer , A.G. Gilman, P.C. Sternweis , and G. Bollag . 1998 . Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13. Science. 280:2112-2114.
28. Hernandez, S.E., M. Krishnaswami, A.L. Miller , and A.J. Koleske. 2004. How do Abl family kinases regulate cell shape and movement? Trends Cell Biol. 14:36-44.
29. Hillen , W. , C. Gatz , L. Altschmied , K. Schollmeier , and I. Meier. 1983. Control of expression of the Tn10-encoded tetracycline resistance genes. Equilibrium and kinetic investigation of the regulatory reactions. J. Mol. Biol. 169:707-721.
30. Holcomb, M., A. Rufni, D. Barila, and R.L. Klemke. 2006. Deregulation of proteasome function induces Abl-mediated cell death by uncoupling p130CAS and c-CrkII. J. Biol. Chem. 281:2430-2440.
31. Hynes, R.O. 1987. Integrins: a family of cell surface receptors. Cell. 48 : 549-554 .
32. Hynes, R.O. 2002. Integrins: bidirectional, allosteric signaling machines. Cell. 110:673-687.
33. Ichiba, T., Y. Hashimoto, M. Nakaya, Y. Kuraishi, S. Tanaka, T. Kurata, N. Mochizuki, and M. Matsuda. 1999. Activation of C3G guanine nucleotide exchange factor for Rap1 by phosphorylation of tyrosine 504. J. Biol. Chem. 274:14376-14381.
34. Jin, H., and J.Y. Wang. 2007. Abl tyrosine kinase promotes dorsal ruff es but restrains lamellipodia extension during cell spreading on fbronectin. Mol. Biol. Cell. 18:4143-4154.
35. Kain, K.H., and R.L. Klemke. 2001 . Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes. J. Biol. Chem. 276:16185-16192.
36. Kain, K.H., S. Gooch, and R.L. Klemke. 2003. Cytoplasmic c-Abl provides a molecular ' Rheostat ' controlling carcinoma cell survival and invasion. Oncogene. 22:6071-6080.
37. Katagiri, K., M. Hattori, N. Minato, S. Irie, K. Takatsu, and T . Kinashi. 2000. Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase. Mol. Cell. Biol. 20:1956-1969.
38. Kimura, K., M. Ito, M. Amano, K. Chihara, Y. Fukata, M. Nakafuku, B. Yamamori, J. Feng, T. Nakano, K. Okawa, et al. 1996. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science. 273:245-248.
39. Kimura, K., Y. Fukata, Y. Matsuoka, V. Bennett, Y. Matsuura, K. Okawa, A. Iwamatsu, and K. Kaibuchi . 1998 . Regulation of the association of adducin with actin f laments by Rho-associated kinase (Rho-kinase) and myosin phosphatase. J. Biol. Chem. 273:5542-5548.
40. Kinch, M.S., M.B. Moore, and D.H. Harpole Jr. 2003. Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival. Clin. Cancer Res. 9:613-618.
41. Kiyokawa, E., Y. Hashimoto, S. Kobayashi, H. Sugimura, T. Kurata, and M. Matsuda . 1998a . Activation of Rac1 by a Crk SH3-binding protein, DOCK180. Genes Dev. 12:3331-3336.
42. Kiyokawa, E., Y. Hashimoto, T. Kurata, H. Sugimura, and M. Matsuda. 1998b. Evidence that DOCK180 up-regulates signals from the CrkII-p130(Cas) complex. J. Biol. Chem. 273:24479-24484.
43. Knudsen, B.S., J. Zheng, S.M. Feller, J.P. Mayer, S.K. Burrell, D. Cowburn, and H. Hanafusa. 1995. Aff nity and specif city requirements for the f rst Src homology 3 domain of the Crk proteins. EMBO J. 14:2191-2198.
44. Kozasa, T., X. Jiang, M.J. Hart, P.M. Sternweis, W.D. Singer , A.G. Gilman, G. Bollag, and P.C. Sternweis. 1998. p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science. 280:2109-2111.
45. Kullander , K. , and R. Klein. 2002. Mechanisms and functions of Eph and ephrin signalling. Nat. Rev. Mol. Cell Biol. 3:475-486.
46. Lawrenson, I.D., S.H. Wimmer-Kleikamp, P. Lock, S.M. Schoenwaelder, M. Down, A.W. Boyd, P.F. Alewood, and M. Lackmann. 2002. Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling. J. Cell Sci. 115:1059-1072.
47. Leng, Y., J. Zhang, K. Badour , E. Arpaia, S. Freeman, P. Cheung, M. Siu, and K. Siminovitch. 2005. Abelson-interactor-1 promotes WAVE2 membrane translocation and Abelson-mediated tyrosine phosphorylation required for WAVE2 activation. Proc. Natl. Acad. Sci. USA. 102:1098-1103.
48. Matsuda, M., Y. Hashimoto, K. Muroya, H. Hasegawa, T. Kurata, S. Tanaka, S. Nakamura, and S. Hattori. 1994. CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells. Mol. Cell. Biol. 14:5495-5500.
49. McWhirter, J.R., and J.Y. Wang. 1993. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosomepositive human leukemias. EMBO J. 12:1533-1546.
50. Miao, H., E. Burnett, M. Kinch, E. Simon, and B. Wang. 2000. Activation of EphA2 kinase suppresses integrin function and causes focal-adhesionkinase dephosphorylation. Nat. Cell Biol. 2:62-69.
51. Miyazaki, T., H. Kato, M. Fukuchi, M. Nakajima, and H. Kuwano. 2003. EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma. Int. J. Cancer. 103:657-663.
52. Moolenaar , W.H. 1995 . Lysophosphatidic acid, a multifunctional phospholipid messenger. J. Biol. Chem. 270:12949-12952.
53. Nagar, B., O. Hantschel, M.A. Young, K. Scheffzek, D. Veach, W. Bornmann, B. Clarkson, G. Superti-Furga, and J. Kuriyan. 2003. Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell. 112:859-871.
54. Noren, N.K., G. Foos, C.A. Hauser, and E.B. Pasquale. 2006. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat. Cell Biol. 8:815-825.
55. Ohba, Y., K. Ikuta, A. Ogura, J. Matsuda, N. Mochizuki, K. Nagashima, K. Kurokawa, B.J. Mayer , K. Maki, J. Miyazaki, and M. Matsuda. 2001. Requirement for C3G-dependent Rap1 activation for cell adhesion and embryogenesis. EMBO J. 20:3333-3341.
56. Okada, S., M. Matsuda, M.Anaf, T. Pawson, and J.E. Pessin. 1998. Insulin regulates the dynamic balance between Ras and Rap1 signaling by coordinating the assembly states of the Grb2-SOS and CrkII-C3G complexes. EMBO J. 17:2554-2565.
57. Parri, M., F. Buricchi, E. Giannoni, G. Grimaldi, T. Mello, G. Raugei, G. Ramponi, and P . Chiarugi . 2007 . EphrinA1 activates a Src/focal adhesion kinase-mediated motility response leading to rho-dependent actino/myosin contractility. J. Biol. Chem. 282:19619-19628.
58. Pasquale , E.B. 2005 . Eph receptor signalling casts a wide net on cell behaviour. Nat. Rev. Mol. Cell Biol. 6:462-475.
59. Pasquale, E.B. 2008. Eph-ephrin bidirectional signaling in physiology and disease. Cell. 133:38-52.
60. Plattner, R. , L. Kadlec , K.A. DeMali , A. Kazlauskas , and A.M. Pendergast . 1999 . c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev. 13:2400-2411.
61. Preyer , M., C.W. Shu, and J.Y. Wang . 2007 . Delayed activation of Bax by DNA damage in embryonic stem cells with knock-in mutations of the Abl nuclear localization signals. Cell Death Differ. 14:1139-1148.
62. Radha, V., A. Rajanna, A. Mitra, N. Rangaraj, and G. Swarup. 2007. C3G is required for c-Abl-induced f lopodia and its overexpression promotes f lopodia formation. Exp. Cell Res. 313:2476-2492.
63. Reedquist, K.A., E. Ross, E.A. Koop, R.M. Wolthuis, F.J. Zwartkruis,Y. van Kooyk, M. Salmon, C.D. Buckley, and J.L. Bos. 2000. The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J. Cell Biol. 148:1151-1158.
64. Ren, R., Z.S. Ye, and D. Baltimore. 1994. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev. 8:783-795.
65. Richter , M. , K.K. Murai, C. Bourgin , D.T. Pak, and E.B. Pasquale. 2007. The EphA4 receptor regulates neuronal morphology through SPAR-mediated inactivation of Rap GTPases. J. Neurosci. 27:14205-14215.
66. Riedl, J.A., D.T. Brandt, E. Batlle, L.S. Price, H. Clevers, and J.L. Bos. 2005. Down-regulation of Rap1 activity is involved in ephrinB1-induced cell contraction. Biochem. J. 389:465-469.
67. Rosen, M.K., T. Yamazaki, G.D. Gish, C.M. Kay, T. Pawson, and L.E. Kay . 1995 . Direct demonstration of an intramolecular SH2-phosphotyrosine inter action in the Crk protein. Nature. 374:477-479.
68. Sahin, M., P.L. Greer, M.Z. Lin, H. Poucher, J. Eberhart, S. Schmidt, T.M. Wright, S.M. Shamah, S. O'Connell, C.W. Cowan, et al. 2005. Ephdependent tyrosine phosphorylation of ephexin1 modulates growth cone collapse. Neuron. 46:191-204.
69. Saito, T., N. Masuda, T. Miyazaki, K. Kanoh, H. Suzuki, T. Shimura, T. Asao, and H. Kuwano . 2004 . Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis. Oncol. Rep. 11:605-611.
70. Sakakibara, A., Y. Ohba, K. Kurokawa, M. Matsuda, and S. Hattori. 2002. Novel function of Chat in controlling cell adhesion via Cas-Crk-C3G- pathwaymediated Rap1 activation. J. Cell Sci. 115:4915-4924.
71. Shamah, S.M., M.Z. Lin, J.L. Goldberg, S. Estrach, M. Sahin, L. Hu, M. Bazalakova, R.L. Neve, G. Corfas,A. Debant, and M.E. Greenberg. 2001. EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell. 105:233-244.
72. Sini , P. , A. Cannas , A.J. Koleske , P.P. Di Fiore , and G. Scita. 2004. Abl-dependent tyrosine phosphorylation of Sos-1 mediates growth-factor-induced Rac activation. Nat. Cell Biol. 6:268-274.
73. Srinivasan, D., and R. Plattner. 2006 . Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells. Cancer Res. 66:5648-5655.
74. Srinivasan, D., J.T. Sims, and R. Plattner. 2007. Aggressive breast cancer cells are dependent on activated Abl kinases for proliferation, anchorageindependent growth and survival. Oncogene. 27:1095-1105.
75. Swimm, A., B. Bommarius, Y. Li, D. Cheng, P. Reeves, M. Sherman, D. Veach, W. Bornmann, and D. Kalman. 2004. Enteropathogenic Escherichia coli use redundant tyrosine kinases to form actin pedestals. Mol. Biol. Cell. 15:3520-3529.
76. Tanaka, S., T. Morishita, Y. Hashimoto, S. Hattori, S. Nakamura, M. Shibuya, K. Matuoka, T. Takenawa, T. Kurata, K. Nagashima, et al. 1994. C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc. Natl. Acad. Sci. USA. 91:3443-3447.
77. Wahl, S., H. Barth, T. Ciossek, K. Aktories, and B.K. Mueller. 2000. Ephrin-A5 induces collapse of growth cones by activating Rho and Rho kinase. J. Cell Biol. 149:263-270.
78. Wang, J.Y. 2004. Controlling Abl: auto-inhibition and co-inhibition? Nat. Cell Biol. 6:3-7.
79. Welch, P.J., and J.Y. Wang. 1995. Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms. Mol. Cell. Biol. 15:5542-5551.
80. Wilkins, J.A., A. Li, H. Ni, D.G. Stupack, and C. Shen. 1996. Control of beta1 integrin function. Localization of stimulatory epitopes. J. Biol. Chem. 271:3046-3051.
81. Woodring, P.J., E.D. Litwack, D.D. O'Leary, G.R. Lucero, J.Y. Wang, and T . Hunter . 2002 . Modulation of the F-actin cytoskeleton by c-Abl tyrosine kinase in cell spreading and neurite extension. J. Cell Biol. 156:879-892.
82. Woodring, P.J., T. Hunter, and J.Y. Wang. 2003. Regulation of F-actindependent processes by the Abl family of tyrosine kinases. J. Cell Sci. 116:2613-2626.
83. Woodring, P.J., J. Meisenhelder, S.A. Johnson, G.L. Zhou, J. Field, K. Shah, F. Bladt, T. Pawson, M. Niki, P.P. Pandolf, et al. 2004. c-Abl phosphorylates Dok1 to promote f lopodia during cell spreading. J. Cell Biol. 165:493-503.
84. Wu, X., B. Knudsen , S.M. Feller , J. Zheng, A. Sali, D. Cowburn, H. Hanafusa, and J. Kuriyan. 1995. Structural basis for the specif c interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure. 3:215-226.